Nemolizumab for genital lichen sclerosus
Treatments studied
Part of Skin, Women’s health & pregnancy clinical trials.
This study tests a new injectable medication called nemolizumab to see if it can reduce itching in women with lichen sclerosus affecting the genital area. If you have severe itching that hasn't been fully controlled by steroid creams, this might be an option to explore.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- Your lichen sclerosus (a skin condition causing itching and discomfort in the genital area) must be confirmed by a skin biopsy.
- You must have had severe itching (score of at least 6 out of 10) in the genital area.
- You must have used a topical corticosteroid (prescription steroid cream) before for this condition.
- You must be willing to stop all other treatments for lichen sclerosus during the study, except for rescue medications allowed by the study doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment for long-lasting vaginal/vulvar irritation caused by conditions like vaginal atrophy or certain skin conditions of the vulva. You would try the study product/device and be followed over time to see how symptoms recover.
This study tests a new medication called nemolizumab for people with lichen planopilaris (LPP), a type of scarring hair loss. It aims to see if the drug can help reduce scalp itching and improve the condition.
This study tests a laser treatment for women with vulvar lichen sclerosus to see if it can help with symptoms like itching, burning, pain, or soreness. It's a option for those who have had a biopsy to confirm the condition.
This study tests an investigational drug called nemolizumab for adults with systemic sclerosis (scleroderma). It aims to see if the drug can help reduce skin thickening and other symptoms, especially in people with early or moderate disease.
This trial tests a cream called delgocitinib for adults with lichen sclerosus in the genital area. It aims to see if the cream can safely and effectively reduce symptoms over 52 weeks.
This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.
Hear when a new Lichen Sclerosus of Vulva trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.